EAACI Congress 2025
BackFT03 - Urticaria and Angioedema
Friday 13 Jun, 13:15 PM -
14:45 PM Glasgow, United Kingdom
Dochart 2
Flash Talks
13:15
000830
Sleep disturbance is a significant mediator between active disease and impaired work productivity in patients with chronic urticaria: Findings from a causal mediation analysis
13:22
001349
Hidden parasitic causes in chronic spontaneous urticaria
13:29
000880
IgE anti-TPO; from acute to chronic urticaria
13:36
001225
The characteristics of Chronic Inducible Urticaria in Cape Town, South Africa
13:43
001209
Impaired vascular autonomic control in HAE patients
13:50
000949
Clinical Validation of a Novel Kinin Biomarker Assay for Characterisation of Bradykinin-Mediated Pathologies in US Subjects with Hereditary Angioedema
13:57
001667
Demographic and diagnostic features of hereditary angioedema patients due to C1 inhibitor deficiency: a large cohort from the Italian network for hereditary and acquired angioedema (ITACA) Registry
14:04
000399
Characterization of pathomechanisms of acute and chronic spontaneous urticaria
14:11
000624
Efficacy and Safety of Donidalorsen for Hereditary Angioedema Among Patients in Europe: A Regional Subanalysis of the Phase 3 OASIS-HAE Study
14:18
001686
Real-World Evaluation of Omalizumab in Chronic Spontaneous and Inducible Urticaria: A Longitudinal Analysis during 15 years from a Lisbon UCARE
